1997
DOI: 10.1016/s0168-8278(97)80113-4
|View full text |Cite
|
Sign up to set email alerts
|

Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
90
0
1

Year Published

1999
1999
2009
2009

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 117 publications
(92 citation statements)
references
References 48 publications
1
90
0
1
Order By: Relevance
“…A high MC density has been demonstrated at wound sites and fibrotic areas in various organs (18,20,21). Furthermore, previous studies have shown a significant relationship between the number of MCs and interstitial fibrosis in renal allografts (11), IgA nephritis (9), and RPGN (10).…”
Section: Discussionmentioning
confidence: 93%
“…A high MC density has been demonstrated at wound sites and fibrotic areas in various organs (18,20,21). Furthermore, previous studies have shown a significant relationship between the number of MCs and interstitial fibrosis in renal allografts (11), IgA nephritis (9), and RPGN (10).…”
Section: Discussionmentioning
confidence: 93%
“…24 In summary, while the present series of observations do not provide direct proof of the existence of a human hepatic stem cell, they add to the growing weight of circumstantial evidence in support of such a concept. There are now several independent reports describing cells in a number of human liver diseases [11][12][13][14][15][16][17]24,39,40 with distinctive morphological or phenotypic features that resemble those characteristic of rodent progenitor cells. 6,7,8,9,35,36 However, questions regarding the cellular lineages of these putative stem cells remain open and will be difficult to resolve by immunohistochemical means alone.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies in recent years have suggested that they are involved in both cholestatic liver disease and hepatic fibrogenesis. [5][6][7][8][9][10][11] With specific reference to autoimmune cholestatic liver disease in humans, Farrell et al 5 and Nakamura et al 7 both found significant increases in mast cell density in patients with primary biliary cirrhosis (PBC).…”
mentioning
confidence: 99%